Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A PolyMedix Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
8-Jan-10 Roth Capital Partners, Inc. Research Department Morning Call Summary 19 $50 View Abstract
8-Jan-10 Roth Capital Partners, Inc. Edward Nash A Strong Platform Technology Begins To Change The Biotech Playing Field 19 $50 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct PolyMedix, Inc. Financial and Strategic Analysis Review 22 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for PYMX 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala POLYMEDIX INC (PYMX=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala POLYMEDIX INC (PYMX=US) 2-weeks forecast 1 $10 View Abstract

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Jan-10 Roth Capital Partners, Inc. Research Department Morning Call Summary 19 $50 View Abstract
8-Jan-10 Roth Capital Partners, Inc. Edward Nash A Strong Platform Technology Begins To Change The Biotech Playing Field 19 $50 View Abstract

Independent Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A PolyMedix Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct PolyMedix, Inc. Financial and Strategic Analysis Review 22 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for PYMX 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala POLYMEDIX INC (PYMX=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala POLYMEDIX INC (PYMX=US) 2-weeks forecast 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.